Search
Abeona Therapeutics Inc
ABEOAdd to Watchlist
5.430USD
-0.100-1.81%
Close 09-24 16:00（ET）
309.51MMarket Cap
4.24P/E TTM
Abeona Therapeutics Inc (ABEO) Stock Price Target & Forecast
Analyst Rating
Based on 7 analysts giving stock ratings to Abeona Therapeutics Inc in the past month.
Buy
3 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
18.875USD+241.32%
ABEO Analyst Recommendation Trends
In the current month, ABEO has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ABEO average Analyst price target in the last month is 18.875.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
3
3
3
3
3
3
3
3
4
3
3
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
6
6
6
6
6
6
6
ABEO Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, ABEO EPS is projected to reach -0.153 in FY2026Q3, following reported EPS of -0.354 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.36
-0.36
-0.23
-0.15
-0.12
Actual
-0.37
-0.30
-0.35
--
--
Surprise
-4.17%
+15.22%
-53.88%
--
--
FAQs
What is Abeona Therapeutics Inc's expected revenue for the next quarter?
Abeona Therapeutics Inc's expected revenue is 16.48M.
What is Abeona Therapeutics Inc's price target?
Analysts forecast that Abeona Therapeutics Inc's price target is USD 18.88, with the highest forecast at USD 30.00 and the lowest forecast at USD 14.00.
How have Abeona Therapeutics IncABEO's recent earnings per share performed?
The market expectation was USD -0.35, while Abeona Therapeutics IncABEO's earnings per share (EPS) for the previous quarter was USD -0.30. EPS for the next quarter is expected at USD -0.15.
What is the analyst rating for Abeona Therapeutics Inc?
Based on the ratings of Abeona Therapeutics Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.